Index
1 Market Overview
1.1 Product Overview and Scope of OTC and DTC Infectious Disease Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of OTC and DTC Infectious Disease Diagnostic by Technology
1.3.1 Overview: Global OTC and DTC Infectious Disease Diagnostic Market Size by Technology: 2018 Versus 2022 Versus 2029
1.3.2 Global OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share by Technology in 2022
1.3.3 PCR
1.3.4 Immunodiagnostics
1.3.5 Clinical Microbiology
1.3.6 INAAT
1.3.7 DNA Sequencing and NGS
1.3.8 DNA Microarrays
1.3.9 Others
1.4 Global OTC and DTC Infectious Disease Diagnostic Market by Application
1.4.1 Overview: Global OTC and DTC Infectious Disease Diagnostic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals and Clinics
1.4.4 Academic Research Institutes
1.4.5 Others
1.5 Global OTC and DTC Infectious Disease Diagnostic Market Size & Forecast
1.6 Global OTC and DTC Infectious Disease Diagnostic Market Size and Forecast by Region
1.6.1 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region, (2018-2029)
1.6.3 North America OTC and DTC Infectious Disease Diagnostic Market Size and Prospect (2018-2029)
1.6.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size and Prospect (2018-2029)
1.6.6 South America OTC and DTC Infectious Disease Diagnostic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.1.4 Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Bio-Rad Laboratories Inc
2.2.1 Bio-Rad Laboratories Inc Details
2.2.2 Bio-Rad Laboratories Inc Major Business
2.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.2.4 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories Inc Recent Developments and Future Plans
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.3.4 BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments and Future Plans
2.4 Bosch Healthcare Solutions GmbH
2.4.1 Bosch Healthcare Solutions GmbH Details
2.4.2 Bosch Healthcare Solutions GmbH Major Business
2.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.4.4 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bosch Healthcare Solutions GmbH Recent Developments and Future Plans
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.5.4 Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Danaher Recent Developments and Future Plans
2.6 ThermoFisher Scientific
2.6.1 ThermoFisher Scientific Details
2.6.2 ThermoFisher Scientific Major Business
2.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.6.4 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ThermoFisher Scientific Recent Developments and Future Plans
2.7 Siemens AG
2.7.1 Siemens AG Details
2.7.2 Siemens AG Major Business
2.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.7.4 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Siemens AG Recent Developments and Future Plans
2.8 Roche Holding AG
2.8.1 Roche Holding AG Details
2.8.2 Roche Holding AG Major Business
2.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.8.4 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Holding AG Recent Developments and Future Plans
2.9 Hologic, Inc.
2.9.1 Hologic, Inc. Details
2.9.2 Hologic, Inc. Major Business
2.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.9.4 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hologic, Inc. Recent Developments and Future Plans
2.10 Qiagen
2.10.1 Qiagen Details
2.10.2 Qiagen Major Business
2.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.10.4 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Qiagen Recent Developments and Future Plans
2.11 Cardinal Health
2.11.1 Cardinal Health Details
2.11.2 Cardinal Health Major Business
2.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.11.4 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cardinal Health Recent Developments and Future Plans
2.12 Quest Diagnostics Incorporated
2.12.1 Quest Diagnostics Incorporated Details
2.12.2 Quest Diagnostics Incorporated Major Business
2.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.12.4 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.13 Ador Diagnostics
2.13.1 Ador Diagnostics Details
2.13.2 Ador Diagnostics Major Business
2.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.13.4 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ador Diagnostics Recent Developments and Future Plans
2.14 Akonni Biosystems, Inc.
2.14.1 Akonni Biosystems, Inc. Details
2.14.2 Akonni Biosystems, Inc. Major Business
2.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.14.4 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Akonni Biosystems, Inc. Recent Developments and Future Plans
2.15 Alveo Technologies
2.15.1 Alveo Technologies Details
2.15.2 Alveo Technologies Major Business
2.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.15.4 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Alveo Technologies Recent Developments and Future Plans
2.16 Binx Health Inc.
2.16.1 Binx Health Inc. Details
2.16.2 Binx Health Inc. Major Business
2.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.16.4 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Binx Health Inc. Recent Developments and Future Plans
2.17 bioMérieux, Inc.
2.17.1 bioMérieux, Inc. Details
2.17.2 bioMérieux, Inc. Major Business
2.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.17.4 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 bioMérieux, Inc. Recent Developments and Future Plans
2.18 Curetis
2.18.1 Curetis Details
2.18.2 Curetis Major Business
2.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.18.4 Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Curetis Recent Developments and Future Plans
2.19 Sysmex Europe GmbH
2.19.1 Sysmex Europe GmbH Details
2.19.2 Sysmex Europe GmbH Major Business
2.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.19.4 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Sysmex Europe GmbH Recent Developments and Future Plans
2.20 Diasorin S.p.A
2.20.1 Diasorin S.p.A Details
2.20.2 Diasorin S.p.A Major Business
2.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product and Solutions
2.20.4 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Diasorin S.p.A Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global OTC and DTC Infectious Disease Diagnostic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of OTC and DTC Infectious Disease Diagnostic by Company Revenue
3.2.2 Top 3 OTC and DTC Infectious Disease Diagnostic Players Market Share in 2022
3.2.3 Top 6 OTC and DTC Infectious Disease Diagnostic Players Market Share in 2022
3.3 OTC and DTC Infectious Disease Diagnostic Market: Overall Company Footprint Analysis
3.3.1 OTC and DTC Infectious Disease Diagnostic Market: Region Footprint
3.3.2 OTC and DTC Infectious Disease Diagnostic Market: Company Product Type Footprint
3.3.3 OTC and DTC Infectious Disease Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Technology
4.1 Global OTC and DTC Infectious Disease Diagnostic Consumption Value and Market Share by Technology (2018-2023)
4.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Technology (2024-2029)
5 Market Size Segment by Application
5.1 Global OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share by Application (2018-2023)
5.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Application (2024-2029)
6 North America
6.1 North America OTC and DTC Infectious Disease Diagnostic Consumption Value by Technology (2018-2029)
6.2 North America OTC and DTC Infectious Disease Diagnostic Consumption Value by Application (2018-2029)
6.3 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country
6.3.1 North America OTC and DTC Infectious Disease Diagnostic Consumption Value by Country (2018-2029)
6.3.2 United States OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
6.3.3 Canada OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
6.3.4 Mexico OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe OTC and DTC Infectious Disease Diagnostic Consumption Value by Technology (2018-2029)
7.2 Europe OTC and DTC Infectious Disease Diagnostic Consumption Value by Application (2018-2029)
7.3 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country
7.3.1 Europe OTC and DTC Infectious Disease Diagnostic Consumption Value by Country (2018-2029)
7.3.2 Germany OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
7.3.3 France OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
7.3.5 Russia OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
7.3.6 Italy OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Consumption Value by Technology (2018-2029)
8.2 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.3.1 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Consumption Value by Region (2018-2029)
8.3.2 China OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8.3.3 Japan OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8.3.4 South Korea OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8.3.5 India OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
8.3.7 Australia OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
9 South America
9.1 South America OTC and DTC Infectious Disease Diagnostic Consumption Value by Technology (2018-2029)
9.2 South America OTC and DTC Infectious Disease Diagnostic Consumption Value by Application (2018-2029)
9.3 South America OTC and DTC Infectious Disease Diagnostic Market Size by Country
9.3.1 South America OTC and DTC Infectious Disease Diagnostic Consumption Value by Country (2018-2029)
9.3.2 Brazil OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
9.3.3 Argentina OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Consumption Value by Technology (2018-2029)
10.2 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country
10.3.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Consumption Value by Country (2018-2029)
10.3.2 Turkey OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
10.3.4 UAE OTC and DTC Infectious Disease Diagnostic Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 OTC and DTC Infectious Disease Diagnostic Market Drivers
11.2 OTC and DTC Infectious Disease Diagnostic Market Restraints
11.3 OTC and DTC Infectious Disease Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 OTC and DTC Infectious Disease Diagnostic Industry Chain
12.2 OTC and DTC Infectious Disease Diagnostic Upstream Analysis
12.3 OTC and DTC Infectious Disease Diagnostic Midstream Analysis
12.4 OTC and DTC Infectious Disease Diagnostic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer